Lebanon: A recent study analyzing data from the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS) has ...

New research being presented at this year's European Congress on Obesity (ECO 2025, Malaga, Spain, 11–14 May) shows that ...

Savvy pharma-stock investors know that an oral GLP-1 drug from Novo Nordisk called Rybelsus has been on the market as a ...

Adults with obesity who used medication and received guidance on resistance training and nutrition lost substantially more ...

Shares of Novo Nordisk, the Danish pharmaceutical company behind weight-loss drugs Ozempic and Wegovy, plummeted this week.

A DAILY weight loss pill that works like Ozempic has succeeded in a major clinical trial. Patients lost an average of a stone and two pounds (7.3kg) each over 10 months. Unhealthy blood sugar ...

GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) have become household names in recent ...

A new oral weight loss pill shows results similar to Ozempic and Wegovy injections in the treatment of obesity.

The once-daily pill, currently under investigation, is being studied for adults with type 2 diabetes who are not on any ...

Eli Lilly said its drugs showed no signs of live injury in the trial. This is welcome news for researchers after Pfizer ...

A YOUNG woman has revealed that she lost over six stone on Mounjaro but has noticed some very strange side effects. Foxy, a singer and musician from the UK, was able to slim down and lose 6 stone ...

A daily weight loss pill that works like breakthrough fat jab Ozempic could be available in the UK as early as next year.